GlassScriptPhysician profile
Walter John Jermakowicz
NPI 1922369750
$38,186.85
in general payments reported to CMS, 2019-2025
19 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $1,010 · 2021: $2,616 · 2022: $1,770 · 2023: $542 · 2024: $452 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,435.01 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies |
| Medtronic USA, INC. | $11,473.88 | 2019-2020 | |
| Stryker Corporation | $2,736.67 | 2020-2023 | 1788, 1688 |
| Abbott Laboratories | $2,134.39 | 2020-2025 | Proclaim, Eterna, Octrode |
| Nevro Corp. | $365.50 | 2020-2022 | |
| Spineology INC. | $332.00 | 2022 | |
| Si-Bone, INC. | $145.25 | 2021 | |
| Cerapedics INC. | $144.20 | 2022 | |
| Globus Medical, INC. | $97.55 | 2025 | Senza |
| Smith+Nephew, INC. | $77.49 | 2022-2025 | Stravix Pl, Grafix Pl, Renasys Go V2 Home |
| Spinefrontier, INC. | $53.36 | 2024 | Inspan |
| Medtronic, INC. | $41.82 | 2021 | |
| Davol INC. | $34.77 | 2020 | |
| Pacira Therapeutics, INC. | $33.07 | 2020-2021 | |
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $18.05 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.55 | 2023 | Andexxa |
| Baudax Bio INC. | $12.25 | 2021 | |
| Heraeus Medical, LLC. | $10.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Jermakowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.